"AUSTIN (KXAN) - After a seven-year battle with cancer, Andrea Sloan died Wednesday evening.
In a Facebook post to the Andi's Army page, Sloan's mother, Karen Sloan, said her daughter died after complications brought on by pneumonia.
Sloan was diagnosed with ovarian cancer seven years ago, at age 37. When her cancer returned in August, Sloan asked California-based drug manufacturer, BioMarin, to grant her compassionate use of their experimental drug, BMN 673, developed specifically to fight her type of genetic ovarian cancer, as well as genetic, or BRCA 1, breast cancer.
But BioMarin repeatedly denied Sloan the drug, citing concerns about safety and effectiveness.
BMN 673 is one of nearly a dozen in a class of drugs called PARP inhibitors currently in clinical trials. Sloan's doctors at MD Anderson believe this class of drugs is her best hope, since all other traditional treatments have been exhausted. But BioMarin would not grant Sloan compassionate use, even though their drug is headed in to Phase 3 trials and has been highly touted by company executives for its results in the first two phases of clinical trials".